Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Patni Rajiv
Relationship:   EVP, Chief R&D Officer
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   89,191    

Indirect Shares

  0      
Direct Value   $1,034,989    

Indirect Value

  $0      
Total Shares   89,191      
Total Value   $1,034,989      


Ocera Therapeutics Inc
 $0 Adamas Pharmaceuticals Inc
 $403,939 Portola Pharmaceuticals Inc
 $631,050 Ocera Therapeutics Inc
 $0 Adamas Pharmaceuticals Inc
 $403,939 Portola Pharmaceuticals Inc
 $631,050
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ocera Therapeutics Inc OCRX Chief Development Offi... 2015-05-07 5,050 2015-05-07 0    Premium*  
            Adamas Pharmaceuticals Inc ADMS Chief Medical Officer 2019-04-08 49,141 2016-03-04 0    Premium*  
            Portola Pharmaceuticals Inc PTLA EVP, CMO 2020-02-28 35,000 2020-02-28 0    Premium*  
            Reata Pharmaceuticals Inc RETA EVP, Chief R&D Officer 2023-09-26 0 2023-06-12 0    Premium*  
* Premium Members only  

Records found :    11         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ADMS Adamas Pharmaceuticals In... Chief Medical Officer   •       –      –    2018-03-21 4 S $25.94 $32,477 D/D (1,252) 21,515 0 -
ADMS Adamas Pharmaceuticals In... Chief Medical Officer   •       –      –    2017-03-21 4 S $17.04 $12,490 D/D (733) 13,642 0 -
ADMS Adamas Pharmaceuticals In... Chief Medical Officer   •       –      –    2016-03-04 4 A $13.66 $102,450 D/D 7,500 7,500 0 -
ADMS Adamas Pharmaceuticals In... Chief Medical Officer   •       –      –    2019-03-20 4 S $8.00 $18,992 D/D (2,374) 19,141 0 -
OCRX Ocera Therapeutics Inc Chief Development Officer   •       –      –    2015-05-07 4 B $3.97 $20,049 D/D 5,050 5,050 2.74 -
ADMS Adamas Pharmaceuticals In... Chief Medical Officer   •       –      –    2017-01-18 4 A $0.00 $0 D/D 6,875 14,375 0 -
ADMS Adamas Pharmaceuticals In... Chief Medical Officer   •       –      –    2018-03-06 4 A $0.00 $0 D/D 9,125 22,767 0 -
ADMS Adamas Pharmaceuticals In... Chief Medical Officer   •       –      –    2019-04-08 4 A $0.00 $0 D/D 30,000 49,141 0 -
PTLA Portola Pharmaceuticals I... EVP, CMO   •       –      –    2020-02-28 4 A $0.00 $0 D/D 35,000 35,000 0 -
RETA Reata Pharmaceuticals Inc EVP, Chief R&D Officer   •       –      –    2023-06-12 4 A $0.00 $0 D/D 45,000 45,000 0 -
RETA Reata Pharmaceuticals Inc EVP, Chief R&D Officer   •       –      –    2023-09-26 4 D $0.00 $0 D/D (45,000) 0 0 -

  11  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed